Aun Consulting
2459
Welby
4438
Value Creation
9238
Perseus Proteomics
4882
DMS
9782
(FY)Nov 30, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.97%8.06B | 3.23%2.38B | 2.68%1.97B | -0.84%7.68B | 0.54%1.76B | -0.31%1.69B | -0.57%2.31B | -2.82%1.92B | 5.65%7.74B | 22.82%1.75B |
Cost of revenue | 4.43%5.99B | -0.10%1.71B | 3.04%1.42B | -2.71%5.74B | -2.39%1.36B | -3.37%1.29B | 1.43%1.71B | -7.10%1.38B | 6.00%5.9B | 16.55%1.4B |
Gross profit | 6.58%2.07B | 12.73%675.67M | 1.78%551.84M | 5.14%1.94B | 12.11%395.71M | 10.85%405.31M | -5.87%599.37M | 10.11%542.19M | 4.57%1.85B | 55.99%352.95M |
Operating expense | -0.17%1.31B | 2.76%341.72M | -1.13%319.34M | 0.67%1.31B | -0.95%326.92M | 3.02%327.52M | 0.34%332.55M | 0.35%323M | 1.07%1.3B | -1.31%330.05M |
Staff costs | -0.29%841.72M | ---- | ---- | 18.12%844.21M | ---- | ---- | ---- | ---- | -0.18%714.68M | ---- |
Other operating expenses | 0.07%466.09M | ---- | ---- | -20.60%465.78M | ---- | ---- | ---- | ---- | 2.64%586.59M | ---- |
Operating profit | 20.56%762.68M | 25.16%333.94M | 6.07%232.5M | 15.77%632.6M | 200.38%68.8M | 63.11%77.79M | -12.60%266.82M | 28.54%219.19M | 13.96%546.42M | 121.17%22.9M |
Net non-operating interest income (expenses) | 15.00%-19.74M | 8.82%-6.67M | 24.74%-5.47M | 9.67%-23.22M | 17.34%-4.47M | 16.47%-4.16M | 4.98%-7.31M | 4.54%-7.27M | 13.93%-25.71M | 26.02%-5.41M |
Non-operating interest income | 33.95%2.02M | -33.33%2K | 27.91%825K | 12.43%1.51M | --0 | 8.42%863K | 0.00%3K | 18.35%645K | 14.29%1.34M | --0 |
Non-operating interest expense | -12.01%21.76M | -8.83%6.67M | -20.45%6.3M | -8.58%24.73M | -17.34%4.47M | -13.04%5.02M | -4.97%7.32M | -3.01%7.92M | -12.86%27.05M | -26.02%5.41M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -92.57%2.57M | 151.57%34.5M | 13.72M | |||||||
Less:Other special charges | 92.57%-2.57M | ---- | ---- | -151.57%-34.5M | ---- | ---- | ---- | ---- | ---13.72M | ---- |
Other non-operating income (expenses) | 11.05%13.51M | -1.36%4.36M | 114.02%4.52M | -20.21%12.16M | -14.39%2.78M | -31.99%2.85M | 0.39%4.42M | -37.88%2.11M | 11.96%15.25M | -2.66%3.25M |
Income before tax | 15.70%759.02M | 25.66%331.63M | 8.18%231.54M | 19.35%656.05M | 194.89%101.61M | 63.05%76.49M | -12.61%263.92M | 28.69%214.03M | 18.66%549.68M | 130.73%34.46M |
Income tax | 0.58%245.82M | 21.26%112.22M | -13.99%62.28M | 19.29%244.4M | 323.48%45.21M | -5.29%34.23M | -9.35%92.55M | 29.37%72.41M | 12.95%204.89M | 144.78%10.68M |
Net income | 24.67%513.2M | 28.03%219.41M | 19.52%169.26M | 19.39%411.64M | 137.17%56.4M | 292.29%42.26M | -14.27%171.37M | 28.35%141.61M | 22.33%344.79M | 126.93%23.78M |
Net income continuous operations | 24.67%513.2M | 28.03%219.41M | 19.52%169.26M | 19.39%411.64M | 137.16%56.4M | 292.29%42.26M | -14.27%171.37M | 28.35%141.61M | 22.33%344.79M | 126.93%23.78M |
Noncontrolling interests | -95.38%405K | 82.60%-1.33M | 2,164.14%5.68M | -56.70%8.76M | 561.03%14.23M | -61.52%1.94M | -277.83%-7.65M | -97.13%251K | 70.48%20.24M | 119.26%2.15M |
Net income attributable to the company | 27.28%512.79M | 23.30%220.74M | 15.71%163.57M | 24.14%402.88M | 94.97%42.17M | 602.00%40.32M | -8.47%179.03M | 39.16%141.36M | 20.22%324.55M | 128.04%21.63M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 27.28%512.79M | 23.30%220.74M | 15.71%163.57M | 24.14%402.88M | 94.97%42.17M | 602.00%40.32M | -8.47%179.03M | 39.16%141.36M | 20.22%324.55M | 128.04%21.63M |
Gross dividend payment | ||||||||||
Basic earnings per share | 27.28%876.87 | 23.30%377.46 | 15.71%279.71 | 24.14%688.92 | 94.89%72.11 | 602.14%68.95 | -8.46%306.13 | 39.18%241.73 | 20.22%554.94 | 128.06%37 |
Diluted earnings per share | 27.28%876.87 | 23.30%377.4577 | 15.71%279.71 | 24.14%688.92 | 94.97%72.1082 | 602.14%68.95 | -8.46%306.13 | 39.18%241.73 | 20.22%554.94 | 128.04%36.9852 |
Dividend per share | 0.00%30 | 0 | 0 | 0.00%30 | 0.00%30 | 0 | 0 | 0 | 0.00%30 | 0.00%30 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |